{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:24:41Z","timestamp":1794255881394,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12325-026-03750-w","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T03:25:20Z","timestamp":1787369120000},"page":"5254-5270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of protein intake deficiency during treatment with GLP-1 and GIP\/GLP-1 receptor agonists: considerations for secondary sarcopenia"],"prefix":"10.1007","volume":"43","author":[{"given":"Konstantinos","family":"Prokopidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cacciatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Batsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"issue":"3","key":"3750_CR1","doi-asserted-by":"publisher","first-page":"afae052","DOI":"10.1093\/ageing\/afae052","volume":"53","author":"B Kirk","year":"2024","unstructured":"Kirk B, Cawthon PM, Arai H, \u00c1vila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: Delphi consensus from the global leadership initiative in sarcopenia (GLIS). Age Ageing. 2024;53(3):afae052.","journal-title":"Age Ageing"},{"key":"3750_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan S, Larsson SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.","journal-title":"Metabolism"},{"key":"3750_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101200","volume":"65","author":"P Wiedmer","year":"2021","unstructured":"Wiedmer P, Jung T, Castro JP, Pomatto LC, Sun PY, Davies KJ, et al. Sarcopenia-molecular mechanisms and open questions. Ageing Res Rev. 2021;65:101200.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"3750_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1017\/S0029665123003555","volume":"82","author":"CH Murphy","year":"2023","unstructured":"Murphy CH, McCarthy SN, Roche HM. Nutrition strategies to counteract sarcopenia: a focus on protein, LC n-3 PUFA and precision nutrition. Proc Nutr Soc. 2023;82(3):419\u201331.","journal-title":"Proc Nutr Soc"},{"key":"3750_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2017.01.001","volume":"40","author":"MA Naseeb","year":"2017","unstructured":"Naseeb MA, Volpe SL. Protein and exercise in the prevention of sarcopenia and aging. Nutr Res. 2017;40:1\u201320.","journal-title":"Nutr Res"},{"issue":"4","key":"3750_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/nutrit\/nuac062","volume":"81","author":"AA Aragon","year":"2023","unstructured":"Aragon AA, Tipton KD, Schoenfeld BJ. Age-related muscle anabolic resistance: inevitable or preventable? Nutr Rev. 2023;81(4):441\u201354.","journal-title":"Nutr Rev"},{"key":"3750_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhip.2025.100585","volume":"9","author":"AA Khaleghi","year":"2025","unstructured":"Khaleghi AA, Salari N, Darvishi N, Bokaee S, Jafari S, Hemmati M, et al. Global prevalence of obesity in the older adults: a meta-analysis. Public Health Pract. 2025;9:100585.","journal-title":"Public Health Pract"},{"issue":"3","key":"3750_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000521241","volume":"15","author":"LM Donini","year":"2022","unstructured":"Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15(3):321\u201335.","journal-title":"Obes Facts"},{"issue":"7","key":"3750_CR9","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1016\/j.clnu.2021.06.009","volume":"40","author":"Q Gao","year":"2021","unstructured":"Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr. 2021;40(7):4633\u201341.","journal-title":"Clin Nutr"},{"issue":"3","key":"3750_CR10","doi-asserted-by":"publisher","first-page":"e243604","DOI":"10.1001\/jamanetworkopen.2024.3604","volume":"7","author":"E Benz","year":"2024","unstructured":"Benz E, Pinel A, Guillet C, Capel F, Pereira B, De Antonio M, et al. Sarcopenia and sarcopenic obesity and mortality among older people. JAMA Netw Open. 2024;7(3):e243604.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"3750_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/nutrit\/nuad007","volume":"81","author":"D Eglseer","year":"2023","unstructured":"Eglseer D, Traxler M, Schoufour JD, Weijs PJ, Voortman T, Boirie Y, et al. Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis. Nutr Rev. 2023;81(9):1077\u201390.","journal-title":"Nutr Rev"},{"issue":"1","key":"3750_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):234.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3750_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4093\/dmj.2025.0106","volume":"49","author":"JS Park","year":"2025","unstructured":"Park JS, Kim KS, Choi HJ. Glucagon-like peptide-1 and hypothalamic regulation of satiation: cognitive and neural insights from human and animal studies. Diabetes Metab J. 2025;49(3):333\u201347.","journal-title":"Diabetes Metab J"},{"issue":"6","key":"3750_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1089\/dia.2024.0533","volume":"27","author":"S Zhang","year":"2025","unstructured":"Zhang S, Yu B, Xu J, Jin S, Li Y, Bing H, et al. Quantitative comparison of glucagon-like peptide-1 receptor agonists on weight loss in adults: a systematic review and model-based meta-analysis. Diabetes Technol Therapeut. 2025;27(6):422\u20139.","journal-title":"Diabetes Technol Therapeut."},{"key":"3750_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/dom.15728","volume":"26","author":"IJ Neeland","year":"2024","unstructured":"Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon\u2010like peptide\u20101\u2010based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26:16\u201327.","journal-title":"Diabetes Obes Metab"},{"key":"3750_CR16","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-25-00478","author":"JA Batsis","year":"2026","unstructured":"Batsis JA, Gavras A, Gross DC, Cheever CR, Da Silva BR, Meira Filho LF, et al. Effect of incretin-based and nonpharmacologic weight loss on body composition: a systematic review. Ann Intern Med. 2026. https:\/\/doi.org\/10.7326\/ANNALS-25-00478.","journal-title":"Ann Intern Med"},{"key":"3750_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70666","author":"N Eisa","year":"2026","unstructured":"Eisa N, Barood O. Lean mass changes with incretin therapy versus lifestyle intervention: a systematic review and meta\u2010analysis of randomised controlled trials. Diabetes Obes Metab. 2026. https:\/\/doi.org\/10.1111\/dom.70666.","journal-title":"Diabetes Obes Metab"},{"key":"3750_CR18","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S531778","author":"Q Ren","year":"2025","unstructured":"Ren Q, Zhi L, Liu H. Semaglutide therapy and accelerated sarcopenia in older adults with type 2 diabetes: a 24-month retrospective cohort study. Drug Des Devel Ther. 2025. https:\/\/doi.org\/10.2147\/DDDT.S531778.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"3750_CR19","volume":"15","author":"D Ashtary-Larky","year":"2017","unstructured":"Ashtary-Larky D, Ghanavati M, Lamuchi-Deli N, Payami SA, Alavi-Rad S, Boustaninejad M, et al. Rapid weight loss vs. slow weight loss: which is more effective on body composition and metabolic risk factors? Int J Endocrinol Metab. 2017;15(3):e13249.","journal-title":"Int J Endocrinol Metab"},{"issue":"7","key":"3750_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1753-4887.2010.00298.x","volume":"68","author":"EM Weinheimer","year":"2010","unstructured":"Weinheimer EM, Sands LP, Campbell WW. A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev. 2010;68(7):375\u201388.","journal-title":"Nutr Rev"},{"issue":"13","key":"3750_CR21","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","volume":"364","author":"DT Villareal","year":"2011","unstructured":"Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364(13):1218\u201329.","journal-title":"N Engl J Med"},{"issue":"8","key":"3750_CR22","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.clnu.2024.06.034","volume":"43","author":"O Anyiam","year":"2024","unstructured":"Anyiam O, Phillips B, Quinn K, Wilkinson D, Smith K, Atherton P, et al. Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus. Clin Nutr. 2024;43(8):1907\u201313.","journal-title":"Clin Nutr"},{"issue":"11","key":"3750_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JP Wilding","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002.","journal-title":"N Engl J Med"},{"key":"3750_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2025.05.022","author":"CM Prado","year":"2025","unstructured":"Prado CM, Gonzalez MC, Norman K, Barazzoni R, Cederholm T, Compher C, et al. Methodological standards for body composition\u2014an expert-endorsed guide for research and clinical applications: levels, models, and terminology. Am J Clin Nutr. 2025. https:\/\/doi.org\/10.1016\/j.ajcnut.2025.05.022.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"3750_CR25","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/dom.14050","volume":"22","author":"MC Dub\u00e9","year":"2020","unstructured":"Dub\u00e9 MC, D\u2019Amours M, Weisnagel SJ. Effect of liraglutide on food consumption, appetite sensations and eating behaviours in overweight people with type 1 diabetes. Diabetes Obes Metab. 2020;22(8):1417\u201324.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"3750_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/dom.14567","volume":"24","author":"S Schmidt","year":"2022","unstructured":"Schmidt S, Frandsen CS, Dejgaard TF, Vistisen D, Halld\u00f3rsson T, Olsen SF, et al. Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes. Diabetes Obes Metab. 2022;24(2):212\u201320.","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"3750_CR27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/dom.12108","volume":"15","author":"A Flint","year":"2013","unstructured":"Flint A, Kapitza C, Zdravkovic M. The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment. Diabetes Obes Metabol. 2013;15(10):958\u201362.","journal-title":"Diabetes Obes Metabol."},{"issue":"7","key":"3750_CR28","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1111\/dom.16395","volume":"27","author":"KM Richardson","year":"2025","unstructured":"Richardson KM, Schembre SM, Jospe MR, Widmer A, Silver HJ. The influence of the glucagon\u2010like peptide\u20101 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: a secondary analysis of a randomized controlled trial. Diabetes Obes Metab. 2025;27(7):3725\u201335.","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"3750_CR29","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1111\/dom.15113","volume":"25","author":"HJ Silver","year":"2023","unstructured":"Silver HJ, Olson D, Mayfield D, Wright P, Nian H, Mashayekhi M, et al. Effect of the glucagon\u2010like peptide\u20101 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: a randomized trial in adults with obesity and prediabetes. Diabetes Obes Metab. 2023;25(8):2340\u201350.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"3750_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.appet.2012.01.014","volume":"58","author":"M S\u00e9n\u00e9chal","year":"2012","unstructured":"S\u00e9n\u00e9chal M, Arguin H, Bouchard DR, Carpentier AC, Ardilouze J-L, Dionne IJ, et al. Effects of rapid or slow weight loss on body composition and metabolic risk factors in obese postmenopausal women. A pilot study. Appetite. 2012;58(3):831\u20134.","journal-title":"Appetite"},{"issue":"10","key":"3750_CR31","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1111\/dom.14477","volume":"23","author":"DR Quast","year":"2021","unstructured":"Quast DR, Nauck MA, Schenker N, Menge BA, Kapitza C, Meier JJ. Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short\u2010and long\u2010acting glucagon\u2010like peptide\u20101 receptor agonists in type 2 diabetes. Diabetes Obes Metab. 2021;23(10):2344\u201353.","journal-title":"Diabetes Obes Metab"},{"key":"3750_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078432","author":"K Yang","year":"1990","unstructured":"Yang K, Yang X, Jin C, Ding S, Liu T, Ma B, et al. Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study. BMJ. 1990. https:\/\/doi.org\/10.1136\/bmj-2023-078432.","journal-title":"BMJ"},{"issue":"11","key":"3750_CR33","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2337\/dc21-0770","volume":"44","author":"RD Leslie","year":"2021","unstructured":"Leslie RD, Evans-Molina C, Freund-Brown J, Buzzetti R, Dabelea D, Gillespie KM, et al. Adult-onset type 1 diabetes: current understanding and challenges. Diabetes Care. 2021;44(11):2449\u201356.","journal-title":"Diabetes Care"},{"issue":"4","key":"3750_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2337\/dci25-0078","volume":"49","author":"AR Kahkoska","year":"2026","unstructured":"Kahkoska AR, Neumiller JJ, Alexopoulos A-S, Barik A, Huang ES, Laffel LM, et al. Challenges and opportunities for improving care for type 1 diabetes in older adulthood. Diabetes Care. 2026;49(4):559\u201370.","journal-title":"Diabetes Care"},{"issue":"5","key":"3750_CR35","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cmet.2025.03.011","volume":"37","author":"E Ravussin","year":"2025","unstructured":"Ravussin E, Sanchez-Delgado G, Martin CK, Beyl RA, Greenway FL, O\u2019Farrell LS, et al. Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation. Cell Metab. 2025;37(5):1060-1074. e1064.","journal-title":"Cell Metab"},{"key":"3750_CR36","doi-asserted-by":"crossref","unstructured":"Martin CK, Carmichael OT, Carnell S, Considine RV, Kareken DA, Dydak U, Mattes RD, Scott D, Shcherbinin S and Nishiyama H. Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial. Nature Med. 2025; pp. 1\u201310.","DOI":"10.1038\/s41591-025-03774-9"},{"issue":"1","key":"3750_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/gerona\/glu103","volume":"70","author":"DR Moore","year":"2015","unstructured":"Moore DR, Churchward-Venne TA, Witard O, Breen L, Burd NA, Tipton KD, et al. Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. J Gerontol Ser A. 2015;70(1):57\u201362.","journal-title":"J Gerontol Ser A"},{"issue":"1","key":"3750_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02596-7","volume":"20","author":"K Jayanama","year":"2022","unstructured":"Jayanama K, Theou O, Godin J, Mayo A, Cahill L, Rockwood K. Relationship of body mass index with frailty and all-cause mortality among middle-aged and older adults. BMC Med. 2022;20(1):404.","journal-title":"BMC Med"},{"issue":"5","key":"3750_CR39","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/jgs.17683","volume":"70","author":"DH Lynch","year":"2022","unstructured":"Lynch DH, Petersen CL, Fanous MM, Spangler HB, Kahkoska AR, Jimenez D, et al. The relationship between multimorbidity, obesity and functional impairment in older adults. J Am Geriatr Soc. 2022;70(5):1442\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"3750_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1017\/S0007114521000799","volume":"127","author":"SF Buhl","year":"2022","unstructured":"Buhl SF, Beck AM, Christensen B, Kock G, Boyle E, Caserotti P. Prevalence of low protein intake in 80+-year-old community-dwelling adults and association with dietary patterns and modifiable risk factors: a cross-sectional study. Br J Nutr. 2022;127(2):266\u201377.","journal-title":"Br J Nutr"},{"issue":"1","key":"3750_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12970-018-0215-1","volume":"15","author":"BJ Schoenfeld","year":"2018","unstructured":"Schoenfeld BJ, Aragon AA. How much protein can the body use in a single meal for muscle-building? Implications for daily protein distribution. J Int Soc Sports Nutrit. 2018;15(1):10.","journal-title":"J Int Soc Sports Nutrit."},{"key":"3750_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155637","volume":"146","author":"R Calvani","year":"2023","unstructured":"Calvani R, Picca A, Coelho-J\u00fanior HJ, Tosato M, Marzetti E, Landi F. Diet for the prevention and management of sarcopenia. Metabolism. 2023;146:155637.","journal-title":"Metabolism"},{"issue":"S2","key":"3750_CR43","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1017\/S0007114512002589","volume":"108","author":"MS Westerterp-Plantenga","year":"2012","unstructured":"Westerterp-Plantenga MS, Lemmens SG, Westerterp KR. Dietary protein\u2013its role in satiety, energetics, weight loss and health. Brit J Nutrit. 2012;108(S2):S105\u201312.","journal-title":"Brit J Nutrit."},{"issue":"1","key":"3750_CR44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ajcnut.2025.04.023","volume":"122","author":"D Mozaffarian","year":"2025","unstructured":"Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344\u201367.","journal-title":"Am J Clin Nutr"},{"issue":"Supplement_1","key":"3750_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/gerona\/glad038","volume":"78","author":"WW Campbell","year":"2023","unstructured":"Campbell WW, Deutz NE, Volpi E, Apovian CM. Nutritional interventions: dietary protein needs and influences on skeletal muscle of older adults. J Gerontol Ser A. 2023;78(Supplement_1):67\u201372.","journal-title":"J Gerontol Ser A"},{"issue":"11","key":"3750_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140903","volume":"10","author":"BT Wall","year":"2015","unstructured":"Wall BT, Gorissen SH, Pennings B, Koopman R, Groen BB, Verdijk LB, et al. Aging is accompanied by a blunted muscle protein synthetic response to protein ingestion. PLoS ONE. 2015;10(11):e0140903.","journal-title":"PLoS ONE"},{"issue":"4","key":"3750_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0320752","volume":"20","author":"M Hetherington-Rauth","year":"2025","unstructured":"Hetherington-Rauth M, McCulloch CE, Evans WJ, Hellerstein M, Shankaran M, Cauley JA, et al. Change in D3Cr muscle mass in oldest old men and its association with changes in grip strength and walking speed. PLoS ONE. 2025;20(4):e0320752.","journal-title":"PLoS ONE"},{"key":"3750_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156113","volume":"164","author":"P Karakasis","year":"2025","unstructured":"Karakasis P, Patoulias D, Fragakis N, Mantzoros CS. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism. 2025;164:156113.","journal-title":"Metabolism"},{"issue":"4","key":"3750_CR49","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3945\/ajcn.116.137232","volume":"105","author":"SK Das","year":"2017","unstructured":"Das SK, Roberts SB, Bhapkar MV, Villareal DT, Fontana L, Martin CK, et al. Body-composition changes in the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE)-2 study: a 2-y randomized controlled trial of calorie restriction in nonobese humans. Am J Clin Nutr. 2017;105(4):913\u201327.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"3750_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.04-2640fje","volume":"19","author":"D Cuthbertson","year":"2005","unstructured":"Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P, et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005;19(3):1\u201322.","journal-title":"FASEB J"},{"issue":"2","key":"3750_CR51","doi-asserted-by":"publisher","first-page":"100820","DOI":"10.1016\/j.jacadv.2023.100820","volume":"3","author":"F Forouzandeh","year":"2024","unstructured":"Forouzandeh F, Alexander K, Forman DE, Kirkpatrick JN, Rich MW, Zieman S, et al. Cardiovascular disease in the older adult: where are we 4 decades later? JACC Adv. 2024;3(2):100820.","journal-title":"JACC Adv."},{"issue":"20","key":"3750_CR52","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1056\/NEJMoa1616338","volume":"376","author":"DT Villareal","year":"2017","unstructured":"Villareal DT, Aguirre L, Gurney AB, Waters DL, Sinacore DR, Colombo E, et al. Aerobic or resistance exercise, or both, in dieting obese older adults. New England J Med. 2017;376(20):1943\u201355.","journal-title":"New England J Med."},{"issue":"4","key":"3750_CR53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s13679-023-00534-z","volume":"12","author":"TA Wadden","year":"2023","unstructured":"Wadden TA, Chao AM, Moore M, Tronieri JS, Gilden A, Amaro A, et al. The role of lifestyle modification with second-generation anti-obesity medications: comparisons, questions, and clinical opportunities. Curr Obesity Rep. 2023;12(4):453\u201373.","journal-title":"Curr Obesity Rep."},{"key":"3750_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/oby.24267","volume":"33","author":"S Dewar","year":"2025","unstructured":"Dewar S. A geriatrician\u2019s approach to managing the complex older adult with obesity. Obesity. 2025;33:41\u201356.","journal-title":"Obesity"},{"issue":"10","key":"3750_CR55","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1210\/clinem\/dgaf335","volume":"110","author":"Z Liu","year":"2025","unstructured":"Liu Z, Weeldreyer NR, Angadi SS. Incretin receptor agonism, fat-free mass, and cardiorespiratory fitness: a narrative review. J Clin Endocrinol Metabol. 2025;110(10):2709\u201317.","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"3750_CR56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/ajcn\/nqaa323","volume":"113","author":"S Szwiega","year":"2021","unstructured":"Szwiega S, Pencharz PB, Rafii M, Lebarron M, Chang J, Ball RO, et al. Dietary leucine requirement of older men and women is higher than current recommendations. Am J Clin Nutrit. 2021;113(2):410\u20139.","journal-title":"Am J Clin Nutrit"},{"issue":"3","key":"3750_CR57","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.clnu.2024.01.031","volume":"43","author":"M Golzarand","year":"2024","unstructured":"Golzarand M, Toolabi K, Mirmiran P. The effects of protein intake higher than the recommended value on body composition changes after bariatric surgery: a meta-analysis of randomized controlled trials. Clin Nutrit. 2024;43(3):708\u201318.","journal-title":"Clin Nutrit."},{"key":"3750_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.clnesp.2024.06.030","volume":"63","author":"Y Kokura","year":"2024","unstructured":"Kokura Y, Ueshima J, Saino Y, Maeda K. Enhanced protein intake on maintaining muscle mass, strength, and physical function in adults with overweight\/obesity: a systematic review and meta-analysis. Clin Nutrit ESPEN. 2024;63:417\u201326.","journal-title":"Clin Nutrit ESPEN."},{"issue":"3","key":"3750_CR59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/nutrit\/nuv065","volume":"74","author":"JE Kim","year":"2016","unstructured":"Kim JE, O\u2019Connor LE, Sands LP, Slebodnik MB, Campbell WW. Effects of dietary protein intake on body composition changes after weight loss in older adults: a systematic review and meta-analysis. Nutrit Rev. 2016;74(3):210\u201324.","journal-title":"Nutrit Rev."},{"key":"3750_CR60","doi-asserted-by":"crossref","unstructured":"Pratley RE, Denham DS, Trivedi R, Watkins E, Connery L, Barnes J, Yu D, Hong J, Simard C and Umans K. Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial. Nat Med. 2026; pp. 1-6.","DOI":"10.1038\/s41591-026-04440-4"},{"key":"3750_CR61","doi-asserted-by":"crossref","unstructured":"Heymsfield SB, Aronne LJ, Montgomery P, Klickstein LB, Coleman LA, Dole K, Mindeholm L, Spruill S, Li X and Attie KM. Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. Nat Med. 2026; 1-14.","DOI":"10.1038\/s41591-026-04204-0"},{"issue":"14","key":"3750_CR62","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jama.2025.14392","volume":"334","author":"MJ Gonzalez-Rellan","year":"2025","unstructured":"Gonzalez-Rellan MJ, Drucker DJ. New molecules and indications for GLP-1 medicines. JAMA. 2025;334(14):1231\u20134.","journal-title":"JAMA"},{"key":"3750_CR63","doi-asserted-by":"crossref","unstructured":"Alissou M, Demangeat T, Folope V, Van Elslande H, Lelandais H, Blanchemaison J, Cailleaux PE, Guney S, Aupetit A and Aubourg A. Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: the SEMALEAN study. Diabet Obes Metabol. 2025","DOI":"10.1016\/j.ando.2025.101860"},{"issue":"4","key":"3750_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2026-116911","volume":"16","author":"AA Alawadhi","year":"2026","unstructured":"Alawadhi AA, Alroudhan D, Alsaeed DJ, Almarshad BW, Alshehabi DH, Allahou BA, et al. LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide therapy (LEAN-PREP study): a protocol for a randomised controlled trial. BMJ Open. 2026;16(4):e116911.","journal-title":"BMJ Open"},{"issue":"10","key":"3750_CR65","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2337\/dci23-0100","volume":"47","author":"JC Locatelli","year":"2024","unstructured":"Locatelli JC, Costa JG, Haynes A, Naylor LH, Fegan PG, Yeap BB, et al. Incretin-based weight loss pharmacotherapy: can resistance exercise optimize changes in body composition? Diabetes Care. 2024;47(10):1718\u201330.","journal-title":"Diabetes Care"},{"issue":"6","key":"3750_CR66","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S2213-8587(25)00027-0","volume":"13","author":"N Sattar","year":"2025","unstructured":"Sattar N, Neeland IJ, Leinhard OD, Land\u00f3 LF, Bray R, Linge J, et al. Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial. Lancet Diabet Endocrinol. 2025;13(6):482\u201393.","journal-title":"Lancet Diabet Endocrinol."}],"updated-by":[{"DOI":"10.1007\/s12325-026-03813-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03750-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03750-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03750-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:03:14Z","timestamp":1794254594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03750-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3750"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03750-w","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to update the in Table 1.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12325-026-03813-y","URL":"https:\/\/doi.org\/10.1007\/s12325-026-03813-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors; Konstantinos Prokopidis, John A. Batsis, Stefano Cacciatore and Stephen D. Anton declares no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}